Assessment of Insulin Resistance and Metabolic Syndrome in Patients with Hypothyroidism: A Case–Control Study at Baquba Teaching Hospital, Diyala, Iraq

Background: Thyroid hormones are key regulators of glucose and lipid metabolism, and hypothyroidism has been linked to insulin resistance and to individual components of the metabolic syndrome. Data from Diyala Governorate, Iraq, are lacking. Objective: To assess insulin resistance and the prevalence of metabolic syndrome in adults with overt and subclinical hypothyroidism compared with euthyroid controls attending Baquba Teaching Hospital. Methods: In this hospital-based case–control study (November 2025 to May 2026), 50 patients with untreated overt hypothyroidism, 50 with untreated subclinical hypothyroidism and 50 age- and sex-matched euthyroid controls were enrolled. Anthropometric measures, blood pressure, fasting plasma glucose, fasting insulin, lipid profile, TSH, free T4, free T3 and anti-thyroid peroxidase antibodies were measured. Insulin resistance was assessed with HOMA-IR, QUICKI and the triglyceride–glucose (TyG) index, and metabolic syndrome was defined according to the 2009 harmonized criteria. Results: Mean HOMA-IR was 4.31 ± 1.82 in overt hypothyroidism, 3.36 ± 1.49 in subclinical hypothyroidism and 1.95 ± 0.88 in controls (p < 0.001); insulin resistance (HOMA-IR ≥ 2.5) was present in 78%, 64% and 18%, respectively. QUICKI was lower and the TyG index higher in both patient groups. Metabolic syndrome was identified in 52%, 38% and 18% of the three groups (p = 0.002). Among patients, TSH correlated positively (r = 0.42) and free T4 inversely (r = −0.36) with HOMA-IR. HOMA-IR (adjusted OR 1.89; 95% CI 1.31–2.73), TSH and BMI were independent predictors of metabolic syndrome. Conclusion: Both overt and subclinical hypothyroidism are associated with significant insulin resistance and a higher prevalence of metabolic syndrome, with a gradient related to the severity of thyroid failure. Routine cardiometabolic screening of hypothyroid patients is recommended.

Authors

Publication Details

Journal
GPH-International Journal of Biological & Medicine Science
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24276504
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Assessment of Insulin Resistance and Metabolic Syndrome in Patients with Hypothyroidism: A Case–Control Study at Baquba Teaching Hospital, Diyala, Iraq

Mohammed Abdul Hadi mohammed, Huda Abdul Hadi Mohammed
2 links
GPH-International Journal of Biological & Medicine Science
Thyroid Disorders and Treatments
article

Assessment of Insulin Resistance and Metabolic Syndrome in Patients with Hypothyroidism: A Case–Control Study at Baquba Teaching Hospital, Diyala, Iraq

Mohammed Abdul Hadi mohammed, Huda Abdul Hadi Mohammed
article en

Abstract

Background: Thyroid hormones are key regulators of glucose and lipid metabolism, and hypothyroidism has been linked to insulin resistance and to individual components of the metabolic syndrome. Data from Diyala Governorate, Iraq, are lacking. Objective: To assess insulin resistance and the prevalence of metabolic syndrome in adults with overt and subclinical hypothyroidism compared with euthyroid controls attending Baquba Teaching Hospital. Methods: In this hospital-based case–control study (November 2025 to May 2026), 50 patients with untreated overt hypothyroidism, 50 with untreated subclinical hypothyroidism and 50 age- and sex-matched euthyroid controls were enrolled. Anthropometric measures, blood pressure, fasting plasma glucose, fasting insulin, lipid profile, TSH, free T4, free T3 and anti-thyroid peroxidase antibodies were measured. Insulin resistance was assessed with HOMA-IR, QUICKI and the triglyceride–glucose (TyG) index, and metabolic syndrome was defined according to the 2009 harmonized criteria. Results: Mean HOMA-IR was 4.31 ± 1.82 in overt hypothyroidism, 3.36 ± 1.49 in subclinical hypothyroidism and 1.95 ± 0.88 in controls (p < 0.001); insulin resistance (HOMA-IR ≥ 2.5) was present in 78%, 64% and 18%, respectively. QUICKI was lower and the TyG index higher in both patient groups. Metabolic syndrome was identified in 52%, 38% and 18% of the three groups (p = 0.002). Among patients, TSH correlated positively (r = 0.42) and free T4 inversely (r = −0.36) with HOMA-IR. HOMA-IR (adjusted OR 1.89; 95% CI 1.31–2.73), TSH and BMI were independent predictors of metabolic syndrome. Conclusion: Both overt and subclinical hypothyroidism are associated with significant insulin resistance and a higher prevalence of metabolic syndrome, with a gradient related to the severity of thyroid failure. Routine cardiometabolic screening of hypothyroid patients is recommended.

GPH-International Journal of Biological & Medicine Science
Good health and well-being
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon